Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,293,556 papers from all fields of science
Search
Sign In
Create Free Account
EDTMP
Known as:
Ethylenediamine Tetra(methylene Phosphonic Acid)
, LEXIDRONAM
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
SAMARIUM Sm153 50 MCI/ML Injectable Solution [Quadramet]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Structural Characterization of Sm(III)(EDTMP).
Y. Yang
,
M. J. Pushie
,
David M.L. Cooper
,
Michael R. Doschak
Molecular Pharmaceutics
2015
Corpus ID: 206685435
Samarium-153 ethylenediamine-N,N,N',N'-tetrakis(methylenephosphonic acid) ((153)Sm-EDTMP, or samarium lexidronam), also known by…
Expand
2014
2014
Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
T. Das
,
H. D. Sarma
,
A. Shinto
,
K. Kamaleshwaran
,
S. Banerjee
Cancer Biotherapy and Radiopharmaceuticals
2014
Corpus ID: 22045051
OBJECTIVE The objective of the present work was to develop a freeze-dried ethylenediaminetetramethylene phosphonic acid (EDTMP…
Expand
2014
2014
Development of novel nanoparticle for bone cancer.
B. F. C. Patricio
,
M. Albernaz
,
M. A. Sarcinelli
,
S. M. de Carvalho
,
R. Santos-Oliveira
,
G. Weissmüller
Journal of Biomedical Nanotechnology
2014
Corpus ID: 9859569
Bone metastasis is responsible for up to 99% of bone tumors. As no cure has yet to be discovered, available treatments simply…
Expand
2011
2011
Phase I trial with a combination of docetaxel and ¹⁵³Sm-lexidronam in patients with castration-resistant metastatic prostate cancer.
Jianqing Lin
,
V. Sinibaldi
,
+4 authors
M. Eisenberger
Urologic oncology
2011
Corpus ID: 35832392
Review
2011
Review
2011
Adverse events in the long-term follow-up of patients treated with samarium Sm 153 lexidronam for osseous metastases.
A. Paravati
,
A. Russo
,
C. Aitken
International Journal of Radiation Oncology…
2011
Corpus ID: 32536984
2008
2008
153Sm: its use in multiple myeloma and report of a clinical experience
E. Abruzzese
,
F. Iuliano
,
M. Trawinska
,
Massimo Di Maio
Expert Opinion on Investigational Drugs
2008
Corpus ID: 19618001
Background: In the past years the bone seeking radiopharmaceutical samarium lexidronam (153Sm-EDTMP) has been increasingly used…
Expand
2007
2007
Samarium Sm 153 lexidronam for the palliative treatment of dogs with primary bone tumors: 35 cases (1999-2005).
Sandra M. Barnard
,
R. Max Zuber
,
Antony S. Moore
Journal of the American Veterinary Medical…
2007
Corpus ID: 24864001
OBJECTIVE To evaluate survival times and palliative effects associated with the use of samarium Sm 153 lexidronam in dogs with…
Expand
2002
2002
153Sm EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies
D. MacFarlane
,
S. Durrant
,
M. Bartlett
,
R. Allison
,
A. Morton
Nuclear medicine communications
2002
Corpus ID: 23755842
This study examined the safety of adding 153Sm lexidronam to standard conditioning regimens in patients undergoing stem cell…
Expand
Highly Cited
1996
Highly Cited
1996
Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach.
Øyvind S. Bruland
,
Arne Skretting
,
Øyvin P. Solheim
,
Magne Aas
Acta oncologica
1996
Corpus ID: 38479658
We report a case where targeted radionuclide therapy using 153Sm-EDTMP gave substantial palliative effect. A 35-year-old male…
Expand
1994
1994
Comparison of biological characteristics of EDTMP complexes with 99mTc, 111In and 153Sm in rats.
M. Lázníček
,
A. Lázníčková
,
F. Budský
,
J. Prokop
,
K. Kopička
Applied Radiation and Isotopes
1994
Corpus ID: 35698545
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE